Medical Affairs | Deciphera

Recent News

August 27, 2026

Vimseltinib for Patients With Tenosynovial Giant Cell Tumor: A Multicenter, Open-Label, Phase 2 Trial

July 13, 2026

IGNITE: A Phase III Study of Tirabrutinib Versus Rituximab and Temozolomide Combination Therapy in Relapsed/Refractory Primary Central Nervous System Lymphoma

July 7, 2026

Expert Video Summary: Results of an Exploratory ctDNA Biomarker Analysis in Advanced GIST

Other Resources

Grant Funding

Through grants, sponsorships and research opportunities, Deciphera is committed to our patients, caregivers, advocacy groups, healthcare providers (HCPs) and researchers. Learn More.

Expanded Access Policy

Deciphera may be able to provide access to an investigational medicine, under certain limited conditions through our Expanded Access Program (EAP) . Learn More.